# Critical role of alpha spectrin in DNA repair: the importance of μ-calpain and Fanconi anemia proteins

**Authors:** Muriel W. Lambert

PMC · DOI: 10.3389/ebm.2025.10537 · Experimental Biology and Medicine · 2025-05-01

## TL;DR

This paper shows that alpha spectrin is crucial for DNA repair, and its breakdown by μ-calpain causes defects in Fanconi anemia.

## Contribution

The study reveals a novel mechanistic link between μ-calpain activity, αSpII stability, and DNA repair in Fanconi anemia.

## Key findings

- Loss of αSpII due to μ-calpain cleavage impairs DNA interstrand crosslink repair in Fanconi anemia cells.
- Knockdown of μ-calpain restores αSpII levels and DNA repair capabilities in FA cells.
- FA proteins are proposed to maintain αSpII stability and prevent its cleavage by μ-calpain.

## Abstract

Nonerythroid spectrins are proteins important in maintaining the structural integrity and flexibility of the cell and nuclear membranes and are essential for a number of functionally important cellular processes. One of these proteins, nonerythroid α spectrin (αSpII), plays a critical role in DNA repair, specifically repair of DNA interstrand crosslinks (ICLs), where it acts as a scaffold, recruiting repair proteins to sites of damage. Loss or breakdown of αSpII is an important factor in a number of disorders. One of these is Fanconi anemia (FA), a genetic disorder characterized by bone marrow failure, chromosome instability, cancer predisposition, congenital abnormalities and a defect in DNA ICL repair. Significantly, breakdown of αSpII occurs in cells from a number of FA complementation groups, due to excessive cleavage by the protease, μ-calpain, leading to defective repair of DNA ICLs in telomeric and non-telomeric DNA. Knockdown of μ-calpain in FA cells by μ-calpain siRNA results in restoration of αSpII levels to normal and repair of DNA ICLs in telomeric and non-telomeric DNA, demonstrating the importance of αSpII stability in the repair process. It is hypothesized that there is a mechanistic link between excessive cleavage of αSpII by μ-calpain and defective DNA ICL repair in FA and that FA proteins, which are deficient in FA, play a key role in maintaining the stability of αSpII and preventing its cleavage by μ-calpain. All of these events are proposed to be important key factors involved in the pathophysiology of FA and suggest new avenues for potential therapeutic intervention.

## Linked entities

- **Genes:** Capn2 (calpain 2) [NCBI Gene 12334]
- **Proteins:** Capn2 (calpain 2)
- **Diseases:** Fanconi anemia (MONDO:0019391)

## Full-text entities

- **Genes:** FANCD2 (FA complementation group D2) [NCBI Gene 2177] {aka FA-D2, FA4, FACD, FAD, FAD2, FANCD}, FANCF (FA complementation group F) [NCBI Gene 2188] {aka FAF}, MUL1 (mitochondrial E3 ubiquitin protein ligase 1) [NCBI Gene 79594] {aka C1orf166, GIDE, MAPL, MULAN, RNF218}, SPTAN1 (spectrin alpha, non-erythrocytic 1) [NCBI Gene 6709] {aka DEE5, DEVEP, EIEE5, HMN11, HMND11, NEAS}, SLX4 (SLX4 structure-specific endonuclease subunit) [NCBI Gene 84464] {aka BTBD12, FANCP, MUS312}, TERF2 (telomeric repeat binding factor 2) [NCBI Gene 7014] {aka TRBF2, TRF2}, MYH14 (myosin heavy chain 14) [NCBI Gene 79784] {aka DFNA4, DFNA4A, FP17425, MHC16, MYH17, NMHC II-C}, ERCC1 (ERCC excision repair 1, endonuclease non-catalytic subunit) [NCBI Gene 2067] {aka COFS4, RAD10, UV20}, FANCL (FA complementation group L) [NCBI Gene 55120] {aka FAAP43, PHF9, POG}, ERCC4 (ERCC excision repair 4, endonuclease catalytic subunit) [NCBI Gene 2072] {aka ERCC11, FANCQ, RAD1, XFEPS, XPF}, TERF1 (telomeric repeat binding factor 1) [NCBI Gene 7013] {aka PIN2, TRBF1, TRF, TRF1, hTRF1-AS, t-TRF1}, MIR1253 (microRNA 1253) [NCBI Gene 100302208] {aka MIRN1253, hsa-mir-1253}, CDC45 (cell division cycle 45) [NCBI Gene 8318] {aka CDC45L, CDC45L2, MGORS7, PORC-PI-1}, FAAP20 (FA core complex associated protein 20) [NCBI Gene 199990] {aka C1orf86, FP7162}, TYRO3 (TYRO3 protein tyrosine kinase) [NCBI Gene 7301] {aka BYK, Dtk, Etk-2, RSE, Rek, Sky}, EPB41 (erythrocyte membrane protein band 4.1) [NCBI Gene 2035] {aka 4.1R, EL1, HE}, EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}, FANCI (FA complementation group I) [NCBI Gene 55215] {aka KIAA1794}, SRC (SRC proto-oncogene, non-receptor tyrosine kinase) [NCBI Gene 6714] {aka ASV, SRC1, THC6, c-SRC, p60-Src}, FANCB (FA complementation group B) [NCBI Gene 2187] {aka FA2, FAAP90, FAAP95, FAB, FACB}, UBE2T (ubiquitin conjugating enzyme E2 T) [NCBI Gene 29089] {aka FANCT, HSPC150, PIG50}, CDC25C (cell division cycle 25C) [NCBI Gene 995] {aka CDC25, PPP1R60}, FANCG (FA complementation group G) [NCBI Gene 2189] {aka FAG, XRCC9}, FANCE (FA complementation group E) [NCBI Gene 2178] {aka FACE, FAE}, RFWD3 (ring finger and WD repeat domain 3) [NCBI Gene 55159] {aka FANCW, RNF201}, CALM1 (calmodulin 1) [NCBI Gene 801] {aka CALML2, CAM2, CAM3, CAMB, CAMC, CAMI}, SUN2 (Sad1 and UNC84 domain containing 2) [NCBI Gene 25777] {aka UNC84B, rab5IP}, FANCA (FA complementation group A) [NCBI Gene 2175] {aka FA, FA-H, FA1, FAA, FACA, FAH}, FAAP100 (FA core complex associated protein 100) [NCBI Gene 80233] {aka C17orf70, FANCX}, IBSP (integrin binding sialoprotein) [NCBI Gene 3381] {aka BNSP, BSP, BSP II, BSP-II, SP-II}, LMNA (lamin A/C) [NCBI Gene 4000] {aka CDCD1, CDDC, CMD1A, CMT2B1, EMD2, FPL}, EMD (emerin) [NCBI Gene 2010] {aka CMD3C, EDMD, LEMD5, STA}, ACP1 (acid phosphatase 1) [NCBI Gene 52] {aka HAAP, LMW-PTP, LMWPTP}, FANCM (FA complementation group M) [NCBI Gene 57697] {aka FAAP250, KIAA1596, POF15, SPGF28}, SYN1 (synapsin I) [NCBI Gene 6853] {aka EPILX, EPILX1, MRX50, SYN1a, SYN1b, SYNI}, FANCC (FA complementation group C) [NCBI Gene 2176] {aka FA3, FAC, FACC}, H2AX (H2A.X variant histone) [NCBI Gene 3014] {aka H2A.X, H2A/X, H2AFX}
- **Diseases:** neuronal degeneration (MESH:D009410), seizures (MESH:D012640), lung cancer (MESH:D008175), absent radi (MESH:D012021), brain and spinal cord anomalies (MESH:D013118), ICL (MESH:D018344), traumatic encephalopathy (MESH:D000070642), cardiac, craniofacial and neural tube abnormalities (MESH:C564271), ataxia (MESH:D001259), Neurological abnormalities (MESH:D009461), telomere dysfunction (MESH:C536801), developmental abnormalities (MESH:D006130), squamous cell carcinoma (MESH:D002294), Chromosomal aberrations (MESH:D002869), microcephaly (MESH:D008831), leukemia (MESH:D007938), neurodevelopmental impairment (MESH:D009422), neurological anomalies (MESH:D009421), brain atrophy (MESH:C566985), Lynch Syndrome (MESH:D003123), neurodegenerative diseases (MESH:D019636), neurodevelopmental diseases (MESH:D004194), Alzheimer's disease (MESH:D000544), mental retardation (MESH:D008607), medulloblastoma (MESH:D008527), hemolytic anemia (MESH:D000743), bone marrow failure (MESH:D000080983), deficiencies in alphaSpII (MESH:D007153), FA (MESH:D005199), B-cell malignant lymphomas (MESH:D016393), epileptic encephalopathy (MESH:D001927), genetic disorder (MESH:D030342), radial ray deformities (MESH:C564523), hydrocephalus (MESH:D006849), cerebellar defects (MESH:D002526), cytopenia (MESH:D006402), cardiac defects (MESH:D006331), congenital abnormalities (MESH:D000013), cancer (MESH:D009369), ear malformations (MESH:D004427), West Syndrome (MESH:D013036), renal deformities (MESH:D006030), AML (MESH:D015470), urogenital anomalies (MESH:D014564), congenital heart failure (MESH:D006333), instability (MESH:D043171)
- **Chemicals:** acetaldehyde (MESH:D000079), 8-methoxysporalen (-), ICLS (MESH:C009813), MMC (MESH:D016685), calcium (MESH:D002118), 4,5'8-trimethylpsoralen (MESH:D014307), PNA (MESH:D020135), psoralen (MESH:D005363), DAPI (MESH:C007293), Cy (MESH:D003545)
- **Species:** Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Homo sapiens (human, species) [taxon 9606], Bos taurus (bovine, species) [taxon 9913], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12078185/full.md

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12078185/full.md

## References

192 references — full list in the complete paper: https://tomesphere.com/paper/PMC12078185/full.md

---
Source: https://tomesphere.com/paper/PMC12078185